The Enterprise Value as of December 2025 (TTM) for Sofiva Genomics Co.,Ltd. (6615.TWO) is 609.02M

According to Sofiva Genomics Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 609.02M. This represents a change of -26.48% compared to the average of 828.38M of the last 4 quarters.

Sofiva Genomics Co.,Ltd. (6615.TWO) Historical Enterprise Value (quarterly & annually)

How has 6615.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Sofiva Genomics Co.,Ltd. over the last ten years is 968.98M. The current 609.02M Enterprise Value has changed 6.19% with respect to the historical average. Over the past ten years (40 quarters), 6615.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 1.64B. The Enterprise Value was at its lowest in in the June 2025 quarter at 640.96M.

Sofiva Genomics Co.,Ltd. (6615.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sofiva Genomics Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sofiva Genomics Co.,Ltd. (6615.TWO) Average Enterprise Value

How has 6615.TWO Enterprise Value performed in the past?

The current Enterprise Value of Sofiva Genomics Co.,Ltd. (6615.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sofiva Genomics Co.,Ltd. (6615.TWO) Enterprise Value vs. Peers

How is 6615.TWO’s Enterprise Value compared to its peers?

Sofiva Genomics Co.,Ltd.’s Enterprise Value is greater than Bioray Biotech Co., Ltd (502.94M), greater than TFBS Bioscience Inc. (556.45M), less than Original BioMedicals Co., Ltd. (840.74M), less than TaiwanJ Pharmaceuticals Co., Ltd. (610.53M), greater than Health & Life Co., Ltd. (546.95M), greater than Vectorite Biomedical Inc. (599.37M), less than EBM Technologies Incorporated (643.54M), greater than Welgene Biotech Co.,Ltd. (407.30M), less than Sunder Biomedical Tech. Co., Ltd. (754.71M), less than AmCad BioMed Corporation (966.32M),

Build a custom stock screener for Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sofiva Genomics Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sofiva Genomics Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.